Online Class Assignment

Capella FlexPath MSN Class Samples:

FPX 6218

FPX 6216

FPX 6212

FPX 6109

FPX 6107

FPX 6414

FPX 6412

FPX 6214

FPX 6021

FPX 6030 Practicum

FPX 6210

FPX 6610

NURS FPX 6218 Assessment 1: Proposing Evidence-Based Change

Capella 6218 Assessment 1

NURS FPX 6218 Assessment 1: Proposing Evidence-Based Change

Student Name

Capella University

School of Nursing and Health Sciences, Capella University

NURS FPX 6218 Assessment 1:

Leading the Future of Health Care

Prof. Name:


Proposing Evidence-Based Change for Allergic Contact Dermatitis Management

Allergic Contact Dermatitis (ACD) is a prevalent skin condition caused by exposure to allergens and chemicals, leading to type IV hypersensitivity reactions. ACD poses significant challenges to patient well-being and often has occupational and environmental implications. Acquired and inborn factors contribute to ACD, making effective management crucial (Nassau & Fonacier, 2020). Nurses are pivotal in ACD care, offering skin care, education, and treatment. Addressing ACD through evidence-based interventions is vital for improved patient outcomes (Thyssen et al., 2022).

Executive Summary- Proposed Change

Enhancing healthcare outcomes for ACD patients requires a multifaceted approach. Empowering patients with knowledge about their condition enables them to identify allergenic triggers and adopt behavioral changes to minimize inflammatory responses. For instance, patients allergic to synthetic rubber can opt for gloves made from non-allergenic materials like carbamates (Dejonckheere et al., 2019). Identifying and eliminating causative agents remains the cornerstone of ACD treatment. Nurses can manage severe cases with antihistamines and corticosteroids, emphasizing allergen avoidance to prevent recurrences (Lipman & Tosti, 2021).

Local or Regional Health Care System for the Proposed Change

Wisconsin’s North Central Health Care (NCHC) system requires a revised approach to ACD care to align with the successful strategies of institutions like the Mayo Clinic (Mayo Clinic, 2023). Patients must be educated about common allergens, such as nickel and fragrances, and adopt practices to mitigate their exposure. Incorporating patient education, environmental modifications, and effective skincare routines can minimize ACD risk (Uter et al., 2020). Leveraging social media platforms can extend awareness and enhance ACD prevention efforts (Nguyen et al., 2021).

NURS FPX 6218 Assessment 1: Proposing Evidence-Based Change

Nurses are pivotal in organizing, assessing, and delivering patient education. They can impart knowledge about ACD’s immunologic basis, preventive measures, proper corticosteroid use, and potential side effects (Thyssen et al., 2022).


Recognizing that understanding a condition does not always translate to behavioral change, tailoring interventions to patients’ developmental stages, prior knowledge, and interactions with healthcare providers is essential for fostering positive actions. NURS FPX 6218 Assessment 1: Proposing Evidence-Based Change. Clear guidelines are imperative to enhance ACD management, encompassing information about allergen sources, symptom recognition, and effective treatments. Preventive strategies, including protective measures and hypoallergenic skincare, should be emphasized to reduce recurrence (Uter et al., 2020).

Desirable Outcomes

The desired outcomes for ACD management include the following:

  1. Identification of allergenic triggers causing ACD.
  2. Prevention strategies to mitigate allergen exposure.
  3. Enhanced patient satisfaction through improved treatment delivery and outcomes.

An interdisciplinary team approach is pivotal for achieving these outcomes, ensuring personalized treatment, education, and follow-up care (Lampel & Powell, 2019).

Limiting Factors

Factors limiting the attainment of desired ACD outcomes include the escalating healthcare costs in the United States. Many insurance plans do not fully cover ACD treatments, leaving patients to bear significant financial burdens. NURS FPX 6218 Assessment 1: Proposing Evidence-Based Change. Patients with limited resources may face difficulty accessing effective treatments, leading to delayed care and worsened conditions (Herman et al., 2021).

Rationale for the Proposed Change

Specific interventions aimed at ACD management can alleviate symptom severity and frequency, improving patient quality of life. Early allergen identification and education contribute to more effective treatments and faster recovery (Ahlström et al., 2019). Research supports the reduction of inflammation and discomfort through allergen avoidance, justifying the proposed changes (Murphy et al., 2019).

Comparative Analysis of Healthcare Systems

Healthcare systems in England, India, and the USA offer comprehensive strategies for ACD management, highlighting the importance of allergen identification, education, and patient satisfaction. Drawing insights from these systems can guide effective ACD care and improve patient outcomes.

Measuring Outcomes

Measurable outcomes can be gauged through data collection on allergen identification, avoidance success rates, and patient satisfaction assessed via surveys.


Implementing evidence-based changes for ACD management can yield financial and health benefits. The proposed interventions, grounded in successful practices, can reduce healthcare costs, enhance patient quality of life, and align the healthcare system with international standards. It is crucial to prioritize patient education, preventive measures, and interdisciplinary collaboration to achieve desirable outcomes for ACD management.


Abbott, L. M., Miller, R., Janda, M., Bennett, H., Taylor, M. L., Arnold, C., Shumack, S., Soyer, H. P., & Caffery, L. J. (2020). A review of literature supporting the development of practice guidelines for teledermatology in Australia. Australasian Journal of Dermatology, 61(2). 

Ahlström, M. G., Thyssen, J. P., Wennervaldt, M., Menné, T., & Johansen, J. D. (2019). Nickel allergy and allergic contact dermatitis: A clinical review of immunology, epidemiology, exposure, and treatment. Contact Dermatitis, 81(4), 227–241. 

Brites, G. S., Ferreira, I., Sebastião, A. I., Silva, A., Carrascal, M., Neves, B. M., & Cruz, M. T. (2020). Allergic contact dermatitis: From pathophysiology to development of new preventive strategies. Pharmacological Research, 162, 105282. 

Dejonckheere, G., Herman, A., & Baeck, M. (2019). Allergic contact dermatitis caused by synthetic rubber gloves in healthcare workers: Sensitization to 1,3‐diphenylguanidine is common. Contact Dermatitis, 81(3), 167–173. 

Goldenberg, A., Ehrlich, A., Machler, B. C., & Jacob, S. E. (2020). Patch test clinic start-up. Dermatitis, 1. 

Gopinath, H., Karthikeyan, K., & Meghana, V. (2020). For the love of color: Plant colors and the dermatologist. Indian Journal of Dermatology, Venereology and Leprology, 86(6), 622. 

Hamza, M., Alam, S., Rizwan, M., & Naz, A. (2022). Health risks associated with arsenic contamination and its biotransformation mechanisms in environment: A review. Emerging Contaminants and Associated Treatment Technologies, 241–288. 

Haque, M. Z., Rehman, R., Guan, L., & Kerr, H. (2022). Recommendations to optimize patient education for allergic contact dermatitis: Our approach. Contact Dermatitis. 

NURS FPX 6218 Assessment 1: Proposing Evidence-Based Change

Herman, A., Uter, W., Rustemeyer, T., Matura, M., Aalto‐Korte, K., Duus Johansen, J., Gonçalo, M., White, I. R., Balato, A., Giménez Arnau, A. M., Brockow, K., Mortz, C. G., Mahler, V., & Goossens, A. (2021). Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices. Journal of the European Academy of Dermatology and Venereology, 35(7), 1444–1448. 

Khan, F. A., Rohatgi, S., Nirhale, S., Manohar, P., Rao, P., Naphade, P., Dave, D., Sravya Kotaru, V., Gupta, S., Gitay, A., & Dubey, P. (2022). Novel transthyretin gene mutation in familial amyloid neuropathy in India: Case. Annals of African Medicine, 21(3), 296. 

Krpata, D. M. (2019). Wound Closure and Management. Surgical Infections, 20(2), 135–138. 

Lampel, H. P., & Powell, H. B. (2019). Occupational and Hand Dermatitis: A practical approach. Clinical Reviews in Allergy & Immunology, 56(1), 60–71. 

Lipman, Z. M., & Tosti, A. (2021). Contact dermatitis in nail cosmetics. Allergies, 1(4), 225–232. 

Mayo Clinic. (2023). Contact dermatitis – Symptoms and causes. Mayo Clinic. 

Michaelis, L. J., Skypala, I. J., Gardner, J., Sheikh, A., Fox, A. T., & Holloway, J. A. (2019). Upskilling healthcare professionals to manage clinical allergy. Clinical & Experimental Allergy, 49(12), 1534–1540. 

Murphy, P. B., Hooten, J. N., Atwater, A. R., & Gossman, W. (2019). Allergic contact dermatitis.; StatPearls Publishing. 

Nassau, S., & Fonacier, L. (2020). Allergic contact dermatitis. Medical Clinics of North America, 104(1), 61–76. 

NCHC. (2023). North Central Health Care. NCHC. 

NICE. (2019). Dermatitis – contact | National Institute for Health and Care Excellence. 

Nguyen, M., Case, S., Botto, N., & Liszewski, W. (2021). The use of social media platforms to discuss and educate the public on allergic contact dermatitis. Contact Dermatitis, 86(3), 196–203. 

Capella 6218 Assessment 1

Rifu, K., Watanabe, J., Sasanuma, H., & Taniguchi, N. (2022). Evaluation of the elasticity of the pancreas using acoustic radiation force impulse elastography in patients with acute pancreatitis: A systematic review and meta-analysis. Ultrasound in Medicine & Biology, 48(3), 406–413. 

Spergel, A. K. R., & Togias, A. (2020). Observational human studies in allergic diseases: Design concepts and highlights of recent National Institute of Allergy and Infectious Diseases-funded research. Current Opinion in Allergy and Clinical Immunology, 20(2), 208. 

Thyssen, J. P., Schuttelaar, M. L. A., Alfonso, J. H., Andersen, K. E., Angelova‐Fischer, I., Arents, B. W. M., Bauer, A., Brans, R., Cannavo, A., Christoffers, W. A., Crépy, M., Elsner, P., Fartasch, M., Filon, F. L., Giménez‐Arnau, A. M., Gonçalo, M., Guzmán‐Perera, M. G., Hamann, C. R., Hoetzenecker, W., & Johansen, J. D. (2022). Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis, 86(5), 357–378. 

Capella 6218 Assessment 1

Uter, W., Werfel, T., Lepoittevin, J.-P., & White, I. R. (2020). Contact Allergy—Emerging Allergens and Public Health Impact. International Journal of Environmental Research and Public Health, 17(7), 2404. 

Xi, Y., Deng, Y.-Q., Chen, S.-M., Kong, Y.-G., Xu, Y., Li, F., Jiao, W.-E., Lu, G., & Tao, Z.-Z. (2022). Allergy-related outcomes and sleep-related disorders in adults: A cross-sectional study based on NHANES 2005–2006. Allergy, Asthma & Clinical Immunology, 18(1).

Claim Your 20% OFF Coupon Code

Welcome — Get your discount offer by providing your email address below
This offer is valid for new customers only.